-
Arvinas to Participate in Upcoming Investor Conferences
-
Arvinas to Present at Upcoming Investor Conferences
-
Arvinas to Present at Upcoming Investor Conferences
-
Arvinas to Participate in Upcoming Virtual Investor Conferences
-
Arvinas to Participate in Upcoming Virtual Investor Conferences
-
Arvinas to Present at the Citi 15th Annual BioPharma Virtual Conference
-
Arvinas to Present at the Citi 15th Annual BioPharma Virtual Conference
-
Citi Upgrades Arvinas Inc. (ARVN) to Buy
-
Arvinas Inc. (ARVN) Prices 4.545M Share Common Offering at $22/Sh
-
Arvinas, Inc. Announces Pricing of Public Offering of Common Stock
-
Arvinas, Inc. Announces Pricing of Public Offering of Common Stock
-
Arvinas Inc. (ARVN) Announces Proposed $90M Offering of Common Stock
-
Arvinas, Inc. Announces Proposed Offering of Common Stock
-
Arvinas, Inc. Announces Proposed Offering of Common Stock
-
Arvinas Inc. (ARVN) PT Lowered to $22 at Citi
-
Citi Downgrades Arvinas Inc. (ARVN) to Neutral
-
Citi Starts Arvinas Inc. (ARVN) at Buy
-
Arvinas (ARVN) IPO Opens 31% Higher
-
Arvinas, Inc. Prices 7.5M Share IPO at $16/Sh
-
Arvinas Announces Pricing of Initial Public Offering

